Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06725823

Therapeutic Effect of Shoulder Anterior Capsular Block Versus Suprascapular Nerve Block in Patients With Frozen Shoulder

he study will include 50 patients with frozen shoulder with no healthy volunteer , Patients in this study will be randomized into two groups suprascapular nerve block and Shoulder anterior capsular block

Recruiting

Interested in participating?

Request Info

Key information

Age range

19 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Sohag university

Sohag, Egypt

Location status: Recruiting

Location contact

Ayat Abdulwahab Othman Mahmoud, MSc

PRINCIPAL_INVESTIGATOR

Hanan S Mohamed AboZaid, professor

CONTACT

[email protected]

01017049050

About this study

The study will include 50 patients with frozen shoulder with no healthy volunteer , Patients in this study will be randomized into two groups according to the treatment performed .

Shoulder anterior capsular block group

Description:

Ultrasound guided injection For the SHAC block, with the patient in a beach-chair position and with the arm in extension, the subscapularis muscle is stretched posteriorly and becomes easily visible. With external rotation and abduction, the coracobrachialis and the biceps brachii muscles are displaced, allowing the visualization of the interfascial space between the deep lamina of the deltoid muscle fascia and the superficial lamina of the subscapularis fascia.Once the injection into the fascial space is achieved, the investigators can proceed towards the glenohumeral pericapsular space by crossing the subscapularis muscle with the needle. By injecting the pericapsular space, the investigators reach the terminal articular branches indistinctly from their origin. Furthermore, through the Weitbrecht foramen, a natural capsular foramen between the upper and middle glenohumeral ligaments, we also reach the intra-articular space .

Suprascapular nerve block group

Description:

Patients will be placed in lateral position by using A high - frequency linear ultrasound probe will be placed approximately 2 cm medial to the medial border of the acromion and about 2 cm cranial to the superior margin of the scapular spine the needle will be inserted .The tip of the needle will be placed at the floor of the supraspinatus fossa where the nerve has passed

  • A volume of (10ml) of 2% lidocaine (2ml), 3% Mepivacaine (2ml) , 1 ml methyl-prednisolone acetate (40 mg) and dextrose 5% (5ml) will be injected to both groups.
  • All patients in both groups will receive immediate stretching exercises and post injection 3 times weekly followed by home exercises

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age above 18 years.
  • Both sexes, males and females.
  • History of complaint >6 weeks
  • Restricted shoulder movement unilaterally in at least 2 planes including abduction, external rotation, and internal rotation and restricted passive movement.

Exclusion criteria

  • Patient refusal.
  • -Allergy to local anaesthetics.
  • -Infection at the site of injection .
  • -Coagulopathy
  • -Prolonged opioid medication
  • -Pregnancy
  • -Acute trauma, fracture of the shoulder
  • People who had received an intra-articular shoulder injection within the last 6 months.
  • Patients with tendon tear

Treatment and study plan

Suprascapular nerve block group

Procedure

A volume of (10 ml) of 2% lidocaine (7ml), 3% Mepivacaine (2ml), 1 ml methyl-prednisolone acetate (40 mg) will be injected to both groups.

shoulder anterior capsular block group

Procedure

A volume of (10ml) of 2% lidocaine (7ml), 3% Mepivacaine (2ml), 1 ml methyl-prednisolone acetate (40mg) will be injected to both groups.

Primary outcomes

  1. Pain (Visual analogue scale)

    Time frame: at baseline and post-procedure at 1, 3 and 6 months.

    s a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" and "worst pain.

  2. total pain scores

    Time frame: at baseline and post-procedure at 1, 3 and 6 months.

    is a combination of simple pain score, radiation, and sleep disturbance score

  3. shoulder pain disability index

    Time frame: at baseline and post-procedure at 1, 3 and 6 months.

    The Shoulder Pain and Disability Index (SPADI) is a self-administered questionnaire that consists of two dimensions, one for pain and the other for functional activities. The pain dimension consists of five questions regarding the severity of an individual's pain. Functional activities are assessed with eight questions designed to measure the degree of difficulty an individual has with various activities of daily living that require upper-extremity use. The SPADI takes 5 to 10 minutes for a patient to complete and is the only reliable and valid region-specific measure for the shoulder.

  4. active range of movement of the shoulder joint

    Time frame: at baseline and post-procedure at 1, 3 and 6 months.

    The active and passive range of abduction, adduction, flexion , extension , internal rotation and external rotation will be measured using goniometry

Study contacts

Contact information is provided by the study sponsor or research team.

Hanan Sayed Mohamed AboZaid, Professor

CONTACT

[email protected]

01017049050

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Official study title

Therapeutic Effect of Shoulder Anterior Capsular Block (SHAC) Versus Suprascapular Nerve Block in Patients With Frozen Shoulder

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Dec 10, 2024
Registry last updated
May 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.